CLINICAL_TRIALS
trial_result
· 2024-02-05
Clinical Trial Update: Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function [Phase 2]
Summary
Phase 2 trial update on eltrombopag for poor graft function has been terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Poor Graft Function | Phase 2 | Status: TERMINATED | Results posted: 2024-02-05